Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.…
Midsona AB (MSON B)
Simris Group (STO: SIMRIS-B) is listed on Nasdaq Stockholm, where its shares trade in SEK. It belongs to the Biotechnology industry, part of the Healthcare sector, and reports about 7 employees.
The shares were at 0.0874 SEK on 20 November 2026, down 22.7% over 52 weeks. Its 52-week range is 0.0402 SEK to 0.1950 SEK: the price is 55.2% below the high and 117.4% above the low.
Its market capitalisation is 117.97M SEK.
Simris Group reports revenue down 51.2% year over year.
It holds more cash than debt, a net cash position of 10.43M SEK. Its Piotroski F-score is 4 out of 9, an average reading of its financial health.
No upcoming events tracked.